4579.T JPX
RaQualia Pharma Inc.
1W: +0.3%
1M: +7.6%
3M: +28.8%
YTD: -40.7%
1Y: -2.7%
3Y: -15.5%
5Y: -46.4%
¥607.00 ($3.85)
-2.00 (-0.33%)
Weekly Expected Move ±4.9%
¥550
¥579
¥609
¥639
¥668
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$357M
-297.1% ▼
Capital Expenditures
$67M
+30.4% ▲
5Y CAGR: -15.5%
Free Cash Flow
-$424M
-603.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$99M
+118.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $881M | $851M | -$324M | -$495M | $273M |
| Depreciation & Amort. | $142M | $148M | $176M | $402M | $488M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$460M | $677M | -$460M | $52M | -$1.2B |
| Other Non-Cash Items | -$197M | -$196M | -$110M | $222M | $59M |
| Operating Cash Flow | $366M | $1.5B | -$719M | $181M | -$357M |
| — Investing Activities — | |||||
| Capital Expenditures | -$105M | -$32M | -$222M | -$97M | -$75M |
| Acquisitions (Net) | -$14M | $0 | $0 | -$3.9B | $0 |
| Investment Purchases | -$718M | -$952M | -$260M | -$200M | -$200M |
| Investment Sales | $544M | $936M | $350M | $359M | $400M |
| Other Investing | $14M | -$1K | -$3M | $152M | -$1M |
| Investing Cash Flow | -$279M | -$48M | -$135M | -$3.7B | $124M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$18M | $12M | $40M | $2.9B | -$589M |
| Stock Repurchased | $0 | $0 | $0 | -$80K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $1K | -$45M | -$52M | $80M | -$50M |
| Financing Cash Flow | -$16M | -$30M | $793M | $3.0B | $380M |
| Net Change in Cash | $179M | $1.4B | -$15M | -$523M | $99M |
| Cash End of Period | $2.2B | $3.7B | $3.7B | $3.1B | $3.2B |
| Free Cash Flow | $261M | $1.4B | -$941M | $84M | -$424M |